Arnie Levine and the MDM2-p53 discovery: a postdoctoral fellow's perspective

Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor.

Cell reports·2026

Reconstructing the Origin and Demographic Expansion of the TP53 p.R337H Founder Variant in Brazil.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025

A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome.

Genome medicine·2025

Cancer associated to low-penetrance TP53 variants: insights from p.R337H.

Trends in cancer·2025

Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery.

Cancer management and research·2024